NP0333136 | Sacrone A | | | C20H30O2
302.4580 Da 302.22458 Da | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) |
|
NP0333137 | Sacrone B | | | C20H28O3
316.4410 Da 316.20384 Da | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) |
|
NP0333138 | Valhidepsin A | | | C40H66N8O8
787.0160 Da 786.50036 Da | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
NP0333139 | Valhidepsin B | | | C40H68N8O9
805.0310 Da 804.51093 Da | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
NP0333140 | Valhidepsin C | | | C38H64N8O8
760.9780 Da 760.48471 Da | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
NP0333141 | Valhidepsin D | | | C38H66N8O9
778.9930 Da 778.49528 Da | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
NP0333142 | Hericenone O | | | C37H54O6
594.8330 Da 594.39204 Da | |
NP0333143 | Hericenone P | | | C35H54O6
570.8110 Da 570.39204 Da | |
NP0333144 | Hericenone Q | | | C37H58O6
598.8650 Da 598.42334 Da | |
NP0333145 | Hericenone R | | | C37H56O6
596.8490 Da 596.40769 Da | |
NP0333146 | Eugeniifoline | | | C21H24N2O3
352.4340 Da 352.17869 Da | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
NP0333147 | Millefolacton B2 | | | C20H27ClO7
414.8800 Da 414.14453 Da | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
NP0333148 | Millefolacton B5 | | | C20H27ClO7
414.8800 Da 414.14453 Da | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
NP0333149 | Millefolacton B8 | | | C20H27ClO7
414.8800 Da 414.14453 Da | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
NP0333150 | Millefolacton B9 | | | C20H27ClO7
414.8800 Da 414.14453 Da | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
NP0333151 | Raufiayunesin A | | | C21H24N2O4
368.4330 Da 368.17361 Da | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
NP0333152 | Raufiayunesin B | | | C20H22N2O4
354.4060 Da 354.15796 Da | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) |
|
NP0333153 | Raufiayunesin C | | | C22H28N2O5
400.4750 Da 400.19982 Da | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
NP0333157 | 7-Butyl-6,8-dihydroxy-3(R)-pent-9,11-dienylisochroman-1-one | | | C18H22O4
302.3700 Da 302.15181 Da | 13C NMR Spectrum (1D, 151 MHz, CD3CN, experimental) | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) | 1H NMR Spectrum (1D, 600 MHz, CD3CN, experimental) |
|
NP0333158 | Persicamidine C | | | C47H74N2O10
827.1130 Da 826.53435 Da | 1H NMR Spectrum (1D, 700 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 176 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) |
|
NP0333159 | Persicamidine E | | | C44H68N2O10
785.0320 Da 784.48740 Da | 1H NMR Spectrum (1D, 700 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | 13C NMR Spectrum (1D, 176 MHz, CD3OD, experimental) | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 700 MHz, CD3OD, experimental) |
|
NP0333160 | Cannabifolin G | | | C25H28O10
488.4890 Da 488.16825 Da | 1H NMR Spectrum (1D, simulated) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) |
|
NP0333161 | Cannabifolin H | | | C23H26O10
462.4510 Da 462.15260 Da | 1H NMR Spectrum (1D, simulated) | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) |
|
NP0333162 | Cannabifolin I | | | C21H22O11
450.3960 Da 450.11621 Da | 1H NMR Spectrum (1D, simulated) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) |
|
NP0333163 | Cannabifolin J | | | C23H28O10
464.4670 Da 464.16825 Da | 1H NMR Spectrum (1D, simulated) | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) |
|